The biotech company, Pila Pharma, is raising 20 million Swedish kronor in an almost fully covered capital raise, which includes…
Read More

The biotech company, Pila Pharma, is raising 20 million Swedish kronor in an almost fully covered capital raise, which includes…
Read More
Biotech Booster, a Dutch valorisation programme that accelerates biotechnological innovations from idea to an investable proposal, was awarded €196.4 million…
Read More
ADVERTISEMENT Stefan Oelrich, president of Bayer’s pharmaceutical division and newly appointed head of the EU’s pharmaceutical lobby EFPIA, pointed out…
Read More